Southport and Ormskirk Hospital NHS Trust

Hospital


Location: Southport, United Kingdom (GB) GB

ISNI: 0000000404654917

ROR: https://ror.org/0586bt104


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group (2024) Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, et al. Journal article Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey (2024) Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, et al. Journal article Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. (2024) Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, et al. Journal article COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys (2023) Jagtap K, Naveen R, Day J, Sen P, Vaidya B, Nune A, Nikiphorou E, et al. Journal article Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023) Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey (2023) Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, et al. Journal article Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023) Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, et al. Journal article Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023) Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023) Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, et al. Journal article
1 2 3